Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women

AIDS

Volumn 15, Issue 3, 2001, Pages 341-345

  Cohen, Ronald A ^a   Boland, Robert ^a   Paul, Robert ^a   Tashima, Karen T ^a   Schoenbaum, Ellie E ^b   Celentano, David D ^c   Schuman, Paula ^d   Smith, Dawn K ^e   Carpenter, Charles C J ^a  

^a BROWN UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

CD4 cell count; HAART; Highly active antiretroviral treatment; Neurocognitive status; Neurocognitive tests

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SUBSTANCE ABUSE; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COGNITION; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; LEARNING; LONGITUDINAL STUDIES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS; VIRAL LOAD;

EID: 0035895643     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200102160-00007     Document Type: Article

References (24)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4+ cell counts from 200 to 500 per cubic millimeter
3. Decay characteristics of HIV-1 infected compartments during combination therapy
4. HIV-1 dynamics in vivo
5. Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: A comparison of simultaneous and alternating regimens
6. Protease inhibitors may reverse AIDS dementia
7. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
8. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia complex
9. CSF, plasma viral load and HIV associated dementia
10. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain
11. Presentation and course of AIDS dementia complex: 10-year follow-up in Amsterdam, the Netherlands
12. The HNRC 500-Neuropsychology of HIV infection at different disease stages
13. Neuropsychological and psychological contributions to quality of life in HIV-infected women
14. Neuropsychological impairment in HIV infection: Implications for employment
15. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
16. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
17. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: A prospective cohort study of human immunodeficiency virus infection in US women
18. HIV-AIDS surveillance report
19. Clinical neuropsychology
20. Color trails
21. Duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir
22. Suppression of plasma viral load below 20 copies/mL is required to achieve a long-term response to therapy